Carmela Nardelli
Naples, 80145, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
CCL2: A Pro-Inflammatory Driver and Candidate Diagnostic Biomarker in Colorectal Cancer Patients.
Journal: International journal of molecular sciences
Published: May 26, 2026
Identification of a weighted urinary microbial signature for bladder cancer discrimination.
Journal: Frontiers in oncology
Published: January 09, 2026
Urinary miR-191-5p levels are significantly reduced after radical prostatectomy in patients with prostate cancer.
Journal: Cancer cell international
Published: July 27, 2025
Genes of the "regulation of lymphocyte activation" pathway may influence immune cells infiltration in growth hormone secreting pituitary tumors.
Journal: Pituitary
Published: May 12, 2025
Clinical Exome Sequencing Study in a Cohort of Growth Hormone-Secreting Pituitary Adenomas.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: May 09, 2025
Insights into Porphyromonas somerae in Bladder Cancer Patients: Urinary Detection by ddPCR.
Journal: Microorganisms
Published: September 04, 2024
Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine Sample.
Journal: European urology open science
Published: November 05, 2023
The performance of multi-gene panels for breast/ovarian cancer predisposition.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: September 22, 2022
Nasal Microbiome in COVID-19: A Potential Role of Corynebacterium in Anosmia.
Journal: Current microbiology
Published: July 06, 2022
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial.
Journal: ESMO open
Published: March 23, 2022
16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer.
Journal: International journal of molecular sciences
Published: August 05, 2021
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma.
Journal: Frontiers in oncology
Published: May 06, 2021
Last Updated: 09/26/2026